Cargando…

Pathophysiology of cholestatic liver disease and its relevance for in vitro tests of hepatotoxicity

Detalles Bibliográficos
Autor principal:	Stöber, Regina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Leibniz Research Centre for Working Environment and Human Factors 2016
Materias:	Editorial Material
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341013/ https://www.ncbi.nlm.nih.gov/pubmed/28275322 http://dx.doi.org/10.17179/excli2016-864

Ejemplares similares

Highlight report: Protection of cholestatic livers by shunting of bile from canaliculi to sinusoids
por: Abbass, Tahany, et al.
Publicado: (2018)

Highlight report: Metabolomics in hepatotoxicity testing
por: Ghallab, Ahmed
Publicado: (2017)

Drug-induced mitochondrial impairment in liver cells
por: Stöber, Regina
Publicado: (2015)

Transcriptomic signature for drug-induced steatosis
por: Stöber, Regina
Publicado: (2015)

Identification of carcinogens by a selected panel of DNA damage response associated genes
por: Stöber, Regina
Publicado: (2015)

Transcriptome based differentiation of harmless, teratogenetic and cytotoxic concentration ranges of valproic acid
por: Stöber, Regina
Publicado: (2014)

Hepatotoxicity: Molecular Mechanisms and Pathophysiology
por: Teschke, Rolf
Publicado: (2019)

Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury
por: Alanazi, Najah S., et al.
Publicado: (2021)

Hepatotoxicity with cholestatic pattern secondary to enoxaparin treatment
por: Velasco de Cos, Guillermo, et al.
Publicado: (2021)

Voriconazole-Induced Cholestatic Hepatotoxicity in an Immune Competent Patient
por: Mohammed, Yaser, et al.
Publicado: (2022)

PTSD in the military: special considerations for understanding prevalence, pathophysiology and treatment following deployment
por: Yehuda, Rachel, et al.
Publicado: (2014)

Liver Pathophysiology—Its Relevance to Human Disease
Publicado: (1971)

Highlight report: Relevance of T-cells, B-cells and immune checkpoint factors for prognosis of breast cancer
por: Myllys, Maiju
Publicado: (2019)

Relevance of genetic disposition versus environmental exposure for cancer risk: an old controversy revisited with novel methods
por: Bolt, H.M.
Publicado: (2013)

Highlight report: The pseudolobule in liver fibrosis
por: Bolt, H.M.
Publicado: (2017)

Targeting leukemia stem cells: in vitro veritas?
por: Bond, Heather M., et al.
Publicado: (2014)

Transcriptomics in developmental toxicity testing
por: Bolt, H. M.
Publicado: (2013)

Liver Transplantation for Patients with Cholestatic Liver Diseases
por: Schöning, Wenzel, et al.
Publicado: (2015)

The Gut-Liver Axis in Cholestatic Liver Diseases
por: Blesl, Andreas, et al.
Publicado: (2021)

Update on pharmacotherapies for cholestatic liver disease
por: Ali, Ahmad H., et al.
Publicado: (2016)

Fibrosis in Autoimmune and Cholestatic Liver Disease
por: Penz-Österreicher, Melitta, et al.
Publicado: (2011)

Review: Pathogenesis of cholestatic liver diseases
por: Yokoda, Raquel T, et al.
Publicado: (2020)

Human non-parenchymal liver cells for co-cultivation systems
por: Ghallab, Ahmed
Publicado: (2014)

Highlight report: Blueprint for stem cell differentiation into liver cells
por: Ghallab, Ahmed
Publicado: (2015)

Highlight report: Intratumoral metabolomic heterogeneity of breast cancer
por: Stoeber, Regina
Publicado: (2017)

Highlight report: Imaging of bile ducts and the bile canalicular network
por: Stoeber, Regina
Publicado: (2019)

Highlight report: Cell type selection for toxicity testing
por: Bolt, H. M.
Publicado: (2018)

Highlight report: Role of the ATP-releasing Panx channels in liver fibrosis
por: González Leiva, Daniela Fernanda
Publicado: (2019)

The rediscovery of HepG2 cells for prediction of drug induced liver injury (DILI)
por: Ghallab, Ahmed
Publicado: (2014)

Highlight report: New insights in liver physiology: Canalicular bile flux is diffusion dominated
por: Ezzat Ahmed, Ahmed
Publicado: (2020)

Recent studies on rosmarinic acid and its biological and pharmacological activities
por: Al-Dhabi, Naif Abdullah, et al.
Publicado: (2014)

Cholestatic liver diseases: An era of emerging therapies
por: Samant, Hrishikesh, et al.
Publicado: (2019)

The Role of Vitamin K in Cholestatic Liver Disease
por: Sultana, Halima, et al.
Publicado: (2021)

Fibrotic Events in the Progression of Cholestatic Liver Disease
por: Wu, Hanghang, et al.
Publicado: (2021)

Guidelines for the Management of Cholestatic Liver Diseases (2021)
por: Lu, Lungen
Publicado: (2022)

Human Hepatocellular response in Cholestatic Liver Diseases
por: Ortiz, Kimberly, et al.
Publicado: (2023)

Evaluation and Management of Chronic Cholestatic Liver Diseases
por: Rini, Sandra Surya, et al.
Publicado: (2023)

Pathophysiology of Chronic Liver Disease Development
por: Fromme, Malin, et al.
Publicado: (2022)

Low risk of hepatotoxicity from rifampicin when used for cholestatic pruritus: a cross‐disease cohort study
por: Webb, G. J., et al.
Publicado: (2018)

Kratom-Induced Cholestatic Liver Injury and Its Conservative Management
por: Fernandes, Christopher T., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gahio0url8jb2koa8kjotved9j